RXRX Recursion Pharmaceuticals, Inc.
$3.27
▼ 4.66%
34
Value
14
P/E-3.09
8
P/B1.69
47
P/S22.06
0
EV/EBITDA-1.74
5
Growth
64
Revenue Growth26.9%
97
EPS Growth14.8%
44
FCF Growth-1.5%
44
Momentum
40
12-Month Return-21.4%
31
3-Month Return-8.1%
47
1-Month Return-3.5%
47
RSI (14)33.76
50
50/200 MABearish
30
Profitability
9
ROE-54.3%
41
ROA-41.8%
0
Gross Margin-34.4%
0
Operating Margin-882.9%
0
Net Margin-844.5%
0
FCF Yield-22.3%
0
Risk
41
Beta1.05
90
60-Day Volatility56.6%
0
QScore Analysis